loadpatents
name:-0.021154880523682
name:-0.027529001235962
name:-0.0015091896057129
Misra; Raj N. Patent Filings

Misra; Raj N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Misra; Raj N..The latest application filed is for "fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function".

Company Profile
0.24.15
  • Misra; Raj N. - Hopewell NJ
  • Misra; Raj N. - Princeton NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
Grant 7,655,689 - Salvati , et al. February 2, 2
2010-02-02
Anthranilic acid derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
Grant 7,569,725 - Kick , et al. August 4, 2
2009-08-04
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
Grant 7,517,904 - Salvati , et al. April 14, 2
2009-04-14
Fused heterocyclic imido and amido compounds
Grant 7,470,797 - Salvati , et al. December 30, 2
2008-12-30
Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
Grant 7,417,040 - Fink , et al. August 26, 2
2008-08-26
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
Grant 7,141,578 - Salvati , et al. November 28, 2
2006-11-28
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
App 20060264459 - Salvati; Mark E. ;   et al.
2006-11-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
App 20060223832 - Salvati; Mark E. ;   et al.
2006-10-05
Anthranilic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
App 20060135619 - Kick; Ellen K. ;   et al.
2006-06-22
Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
App 20050272799 - Salvati, Mark E. ;   et al.
2005-12-08
Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
App 20050250753 - Fink, Brian E. ;   et al.
2005-11-10
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
App 20050192253 - Salvati, Mark E. ;   et al.
2005-09-01
Process for preparing azacycloalkanoylaminothiazoles (LD 137e)
Grant 6,897,321 - Chen , et al. May 24, 2
2005-05-24
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
App 20040077605 - Salvati, Mark E. ;   et al.
2004-04-22
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
Grant 6,720,347 - Rawlins , et al. April 13, 2
2004-04-13
Process for preparing azacycloalkanoylaminothiazoles (LD 137e)
App 20040063767 - Chen, Bang-Chi ;   et al.
2004-04-01
Process for preparing azacycloalkanoylaminothiazoles
Grant 6,639,074 - Chen , et al. October 28, 2
2003-10-28
Process for preparing arylacetylaminothiazoles
Grant 6,613,911 - Chen , et al. September 2, 2
2003-09-02
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
Grant 6,515,004 - Misra , et al. Fe
2003-02-04
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
App 20020165259 - Rawlins, David B. ;   et al.
2002-11-07
Aminothiazole inhibitors of cyclin dependent kinases
App 20020137778 - Kim, Kyoung S. ;   et al.
2002-09-26
Process for preparing azacycloalkanoylaminothiazoles
App 20020099217 - Chen, Bang-Chi ;   et al.
2002-07-25
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
Grant 6,407,124 - Rawlins , et al. June 18, 2
2002-06-18
Process for preparing arylacetylaminothiazoles
App 20020072609 - Chen, Bang-Chi ;   et al.
2002-06-13
Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]- pyridines as cyclin dependent kinase inhibitors
App 20020002178 - Misra, Raj N.
2002-01-03
Aminothiazole inhibitors of cyclin dependent kinases
Grant 6,262,096 - Kim , et al. July 17, 2
2001-07-17
Process for preparing azacycloalkanoylaminothiazoles
App 20010006976 - Chen, Bang-Chi ;   et al.
2001-07-05
Process for preparing arylacetylaminothiazoles
App 20010004639 - Chen, Bang-Chi ;   et al.
2001-06-21
Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitors
Grant 6,107,305 - Misra , et al. August 22, 2
2000-08-22
Aminothiazole inhibitors of cyclin dependent kinases
Grant 6,040,321 - Kim , et al. March 21, 2
2000-03-21
Prostaglandin analogs
Grant 5,827,868 - Misra , et al. October 27, 1
1998-10-27
Heteroaromatic amine thrombin inhibitors
Grant 5,371,091 - Misra , et al. December 6, 1
1994-12-06
Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
Grant 5,332,822 - Misra July 26, 1
1994-07-26
7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
Grant 5,153,327 - Misra , et al. October 6, 1
1992-10-06
7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
Grant 5,100,889 - Misra , et al. March 31, 1
1992-03-31
Quinoline compounds and compositions thereof
Grant 4,814,454 - Misra March 21, 1
1989-03-21
Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents
Grant 4,757,078 - Misra July 12, 1
1988-07-12
Arachidonic acid analogs
Grant 4,599,439 - Misra July 8, 1
1986-07-08
2-Pyridylcarboxamides which inhibit arachidonic acid release
Grant 4,555,520 - Misra , et al. November 26, 1
1985-11-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed